Multilevel systems biology analysis identifies key immune response profiles and potential correlates of protection for M72/AS01E vaccine against tuberculosis
Our results provided new insights into M72/AS01E immunity, warranting further study to optimize and guide future TB vaccine development.
Authors
- Oluwaseun Oluwatosin Taofeek (ORCID: https://orcid.org/0000-0002-3076-4648)
- Lateef Adegboyega Sulaimon (ORCID: https://orcid.org/0000-0002-5530-6205)
- Louis Odinakaose Ezediuno (ORCID: https://orcid.org/0000-0002-9491-529X)
- Phillip Owiti
- E.P. Evans
- Olawale Moses Oyewole (ORCID: https://orcid.org/0009-0009-1827-8434)
- Solomon Osarumwense Alile (ORCID: https://orcid.org/0000-0002-7853-8818)
- Ifeoluwa Adeniyi George
Institutions
- Crescent University (NG)
- Federal University of Agriculture, Abeokuta (NG)
- Jomo Kenyatta University of Agriculture and Technology (KE)
- Kenya AIDS Vaccine Initiative (KE)
- Pan-Atlantic University (NG)
- University of Benin (NG)
Publication Details
- Journal
- Clinical and Experimental Vaccine Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.7774/cevr.2025.14.e21
- Citations
- 1
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.81